Objective. To determine whether IgG subclasses of Borrelia burgdorferi antibodies differ from those of 3 Lyme disease (LD)-associated autoantibodies.
Methods. IgG antibody subclasses were determined by enzyme-linked immunosorbent assay in serum samples from 215 patients with features representative of each of the 3 stages of LD. Antibody and cytokine profiles were measured in matched serum and synovial fluid (SF) samples from patients with Lyme arthritis. Synovial tissue from patients with antibiotic-refractory arthritis was examined for histologic features, IgG subclasses of plasma cells, and messenger RNA (mRNA) subclass expression.
Results. B burgdorferi antibodies were primarily of the IgG1 and IgG3 subclasses, and the levels increased as the infection progressed. In contrast, LD-associated autoantibodies were mainly of the IgG2 and IgG4 subclasses, and these responses were found primarily in patients with either antibiotic-refractory or antibioticresponsive arthritis, particularly in SF. However, compared with the responsive group, the inflammatory milieu in SF in the refractory group was enriched for cytokines representative of innate, Th1, Th2, and Th17 responses. Synovial tissue in a subgroup of patients with refractory arthritis showed marked expression of mRNA for IgG4 antibodies and large numbers of IgG4-staining plasma cells. IgG4 autoantibodies in SF to each of the 3 LD-associated autoantigens correlated with the magnitude of obliterative microvascular lesions and fibrosis in the tissue.
Conclusion. Our findings indicate that the subclasses of IgG antibodies to B burgdorferi differ from those of LD-associated autoantibodies. Furthermore, the correlation of IgG4 autoantibodies with specific synovial pathology in the refractory group suggests a role for these autoantibodies, either protective or pathologic, in antibiotic-refractory Lyme arthritis.
Lyme disease (LD), which is caused by the ticktransmitted spirochete Borrelia burgdorferi, usually begins with an expanding skin lesion, erythema migrans (stage 1) (1). Weeks later, patients who do not receive antibiotic therapy may develop neurologic involvement or carditis (stage 2), and months later, untreated patients commonly have Lyme arthritis (stage 3). Patients with each manifestation of the illness usually respond to appropriate antibiotic therapy (2) , but postinfectious syndromes may delay recovery (3) . For example, a small percentage of patients with Lyme arthritis have persistent synovitis for months or several years despite spirochetal killing with 2-3 months of oral and intravenous (IV) antibiotics, called postinfectious, antibiotic-refractory Lyme arthritis (4) .
As the infection progresses, IgG antibody responses to B burgdorferi expand gradually to an increasing array of spirochetal proteins (5) , and these responses are important in the control of this large, extracellular pathogen (3, 6) . In addition, we have identified 4 autoantigens, endothelial cell growth factor (ECGF), matrix metalloproteinase 10 (MMP-10), apolipoprotein B-100 (Apo B-100), and annexin A2, that are targets of T and B cell responses in LD, particularly in antibiotic-refractory Lyme arthritis (7) (8) (9) (10) . IgG autoantibodies to annexin A2 may be found in several rheumatic diseases (11) , but the other 3 autoantibodies (called here LD-associated autoantibodies) are found primarily or exclusively in LD. In this study, we focused on the 3 LD-specific autoantibodies.
IgG antibodies are separated into 4 subclasses (IgG1-4) (12). IgG1 is the most common subclass, and in healthy individuals, it accounts for~60% of IgG antibodies in serum. IgG4 is the least abundant subclass, accounting for only 5% of serum IgG antibodies (13) . IgG1 and IgG3 antibodies, which engage Fcc receptors, fix complement, and promote opsonization, are generally activating antibodies (14, 15) , and IgG3 antibodies are especially potent inducers of antibody-dependent cell cytotoxicity (16) . In contrast, IgG2 and IgG4 antibodies often have noninflammatory effects (15, 17) . Previous investigators have reported that antibodies to B burgdorferi were primarily of the IgG1 and IgG3 subclasses (18, 19) , the levels of IgG2 B burgdorferi antibodies were generally low, and IgG4 antibody levels were below the level of detection (19) . However, the antibody subclasses of LD-associated autoantibodies were not yet known.
Herein, we characterized the IgG subclasses of antibodies to B burgdorferi and 3 LD-associated autoantigens in each of the 3 stages of LD. We found that B burgdorferi antibodies were primarily of the IgG1 and IgG3 subclasses, as reported previously (18, 19) , whereas the LD-associated autoantibodies were primarily of the IgG2 and IgG4 subclasses. Moreover, in postinfectious antibiotic-refractory Lyme arthritis, IgG4 autoantibodies to each autoantigen, measured in synovial fluid (SF), correlated directly with the magnitude of obliterative microvascular lesions and fibrosis in synovial tissue, suggesting a role for these autoantibodies in disease pathogenesis.
PATIENTS AND METHODS
Study patients. Serum samples, collected from 1988 through 2016, from 215 patients who had manifestations that were representative of each of the 3 stages of LD were analyzed. SF from 47 of the 137 patients with Lyme arthritis was available for testing. All patients with LD met the Centers for Disease Control and Prevention criteria (20) . For comparison, serum samples were obtained from 16 healthy control subjects and 9 blood bank donors. The Human Investigation Committees at Tufts Medical Center (1988 and 2002) and Massachusetts General Hospital (MGH) (2002-2016) approved the study, titled "Immunity in Lyme Disease," and all patients (including parents of patients ages 12-18) provided written informed consent.
Enzyme-linked immunosorbent assay (ELISA) for antibodies to B burgdorferi or LD-associated autoantigens. All antibody responses were determined by ELISA. B burgdorferi sonicate (strain G39/40) (5 lg/ml) or recombinant human MMP-10 (R&D Systems), human Apo B-100 (Millipore), or ECGF (R&D Systems) (in each instance, 2.5 lg/ml) diluted in carbonate coating buffer was added to Immulon 1B ELISA plates (Thermo Scientific), and incubated overnight at 4°C. After washing with phosphate buffered saline (PBS) with 0.05% Tween 20 between each step, the plates were incubated with 3% bovine serum albumin (Sigma-Aldrich) in PBS blocking buffer, followed by incubation with patient serum or SF samples (1:100), in each instance for 1 hour on an orbital shaker (200 revolutions per minute). The secondary antibodies were horseradish peroxidase-conjugated mouse anti-human IgG1, IgG2, IgG3, or IgG4 Fc antibodies (Life Sciences), which were incubated for 2 hours on a shaker, followed by incubation with tetramethylbenzidine substrate (BD Biosciences). For interplate standardization, 1 positive patient control and 2 negative controls were included on each plate. A positive antibody response was defined as >3 SD above the mean value in healthy control subjects.
Cytokine analyses. were assessed in serum or SF samples from patients with Lyme arthritis using bead-based Luminex multiplex assays (EMD Millipore). Because sample volumes were limited, the levels of all mediators were determined in one complete experiment.
Immunohistologic analysis of synovial tissue. Histologic and immunohistologic analyses were previously performed with synovial tissue from patients with antibiotic-refractory Lyme arthritis (21) . Histologic findings in 13 patients were ranked from 1 to 13, with 13 being the highest ranked patient (21) . This ranking was carried out by 2 independent pathologists prior to the determination of antibody responses in the present study. For this study, the absorbance value for each IgG subclass of antibodies to B burgdorferi, MMP-10, ECGF, and Apo B-100 in the 13 patients was also ranked from 1 to 13, with 13 being the highest absorbance value. Correlations were then performed between each histologic parameter and antibody specificity.
In addition, remaining synovial tissue, which was available for 10 of the 13 patients, was stained for plasma cells (VS38c; Dako) and for the IgG subclasses of these cells. After blocking, sections were incubated with anti-human IgG1, IgG2, IgG3, or IgG4 rabbit monoclonal antibody (RevMAb Biosciences) for 30 minutes. Optimal concentrations were used according to the manufacturer's specifications. After washing, sections were incubated with biotinylated anti-rabbit secondary antibody, peroxidaseconjugated streptavidin, and then diaminobenzidine chromogen substrate (Dako). Slides were counterstained with Mayer's hematoxylin and mounted with Permount. Microscopic images were obtained with a Zeiss widefield microscope.
Expression of messenger RNA (mRNA) for IgG subclasses in synovial tissue. Expression of mRNA for the IgG subclasses was determined in synovia from 14 patients with antibiotic-refractory Lyme arthritis and from 5 patients each with rheumatoid arthritis (RA) or osteoarthritis (OA) who underwent synovectomies or joint replacement procedures. Tissue was placed immediately in RNAlater and stored at À20°C. RNA was recovered from~100 mg of synovial tissue using a miRNeasy kit (Qiagen), and quality was determined using a Bioanalyzer (Agilent). Ribosomal RNA was depleted using Ribo-Zero (New England Biolabs), and paired-end libraries were prepared using the NEBNext Ultra RNA Library Prep Kit for Illumina (New England Biolabs). Libraries were sequenced to a depth of 25-35 1836 SULKA ET AL million paired-end, 50 base pair filtered reads, resulting in~40% transcriptome coverage (HiSeq PE50 Reagent Kit; Illumina). Library preparation, sequencing, and bioinformatics analysis were performed at the MGH NextGen Sequencing and Bioinformatics Core Facilities. Statistical analysis. IgG antibodies of each subclass were compared among patients with each of the 3 stages of LD and between patients with responsive and refractory Lyme arthritis using unpaired t-test with Welch's correction. Subclasses in paired serum and SF samples were compared using paired t-test with Welch's correction. Correlations were analyzed using Spearman's correlation test. All analyses were performed using GraphPad Prism 6. For analysis of high-throughput RNA sequencing, adjusted P values were determined by calculating differential expression between groups, normalizing expression to copies per million base pair reads.
RESULTS
IgG subclass analysis of each of the 3 stages of LD. The subclasses of IgG antibodies to B burgdorferi and 3 LD-associated autoantibodies were determined by ELISA in serum samples from 215 patients with LD. These included patients with erythema migrans (stage 1), neuroborreliosis or carditis (stage 2), or Lyme arthritis (stage 3), the most common late manifestation of the disease in the US.
With each disease manifestation, B burgdorferi antibodies were primarily of the IgG1 and IgG3 subclasses, the subtypes that fix complement and opsonize pathogens. The levels of these antibodies were low in patients with , and patients with Lyme arthritis (arth; n = 136) were determined by enzyme-linked immunosorbent assay. Symbols represent individual subjects. Shaded areas correspond to 3 SD above the mean value in healthy controls. P values were determined by unpaired t-test with Welch's correction. Only significant differences are shown. erythema migrans, intermediate in those with neuroborreliosis or carditis, and highest in those with Lyme arthritis ( Figure 1A ). In contrast, the IgG2 and IgG4 antibodies to B burgdorferi were either found at low levels or were negative in patients with early manifestations of the disease, but were found at significantly higher levels in those with Lyme arthritis.
The subclasses of IgG antibodies to the 3 LDassociated autoantigens were different from those of B burgdorferi antibodies. The autoantibody responses were primarily of the IgG2 and IgG4 subclasses, although a few patients had low levels of IgG1 and IgG3 autoantibodies ( Figure 1B) . Small numbers of patients with erythema migrans (stage 1) or neuroborreliosis or carditis (stage 2) had autoantibody responses, whereas larger numbers of patients with Lyme arthritis (stage 3) had these responses. The only exception was patients with carditis, who had significantly higher levels of IgG3 Apo B-100 autoantibodies than those with erythema migrans or arthritis. Taken together, our findings indicate that anti-B burgdorferi Figure 2 . IgG subclasses of Borrelia burgdorferi antibodies and 3 Lyme disease (LD)-associated autoantibodies in the serum of patients with antibiotic-responsive Lyme arthritis (Res; n = 55) and patients with antibiotic-refractory Lyme arthritis (Ref; n = 82) and in the synovial fluid (SF) of patients with antibiotic-responsive arthritis (n = 17) and patients with antibiotic-refractory arthritis (n = 31). For each assay, the antibody responses to B burgdorferi (A) or the LD autoantigens matrix metalloproteinase 10 (MMP-10), endothelial cell growth factor (ECGF), and apolipoprotein B-100 (Apo B-100) (B) were determined by enzyme-linked immunosorbent assay. Symbols represent individual patients; horizontal lines show the mean. Shaded areas correspond to 3 SD above the mean value in healthy controls. P values were determined by unpaired t-test with Welch's correction. Only significant differences are shown.
antibodies were primarily of the IgG1 and IgG3 subclasses throughout the illness, whereas autoantibodies were more often of the IgG2 and IgG4 subclasses, and these responses were found primarily in patients with Lyme arthritis.
Antibodies in responsive or refractory Lyme arthritis. We next determined whether the antibody responses to B burgdorferi or the 3 autoantigens differed in serum and SF in patients with responsive or refractory arthritis. Because joint swelling in patients with antibiotic-responsive arthritis resolves with antibiotic treatment, samples in the responsive group were obtained prior to or soon after starting antibiotic therapy when patients were still infected. In contrast, patients in the refractory group were usually referred after antibiotic therapy when few, if any, spirochetes remained. Of the 137 patients with Lyme arthritis, 117 (85%) were seen in the most recent decade (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) , and only 10 patients were seen in each of the 2 previous decades. There was no correlation between antibody levels and the decade in which the patient had arthritis.
The levels of IgG1 and IgG3 B burgdorferi antibodies tended to be higher in patients with antibiotic-responsive Lyme arthritis than in those with antibiotic-refractory arthritis, and the levels were higher in SF than in serum (Figure 2A) . Conversely, the levels of IgG2 antibodies to B burgdorferi were significantly higher in patients with antibiotic-refractory arthritis, but these values were higher in serum than in SF. A few patients in the refractory and responsive groups had IgG4 antibodies to B burgdorferi in serum, but not in SF.
In contrast to B burgdorferi antibodies, IgG2 and IgG4 were the prominent subclasses of each of the 3 LDassociated autoantibodies. IgG4 antibodies to MMP-10 were significantly greater in SF than in serum in patients with refractory arthritis and those with responsive arthritis ( Figure 2B ). For ECGF, the levels of each IgG subclass were greater in serum, except for IgG4 antibodies, levels of which were similar in serum and SF in both the antibiotic-responsive and antibiotic-refractory groups. For Apo B-100, the levels of each IgG subclass were greater in SF in patients with antibiotic-refractory arthritis than in those with antibiotic-responsive arthritis, particularly IgG2 and IgG4 antibodies, and the values in SF tended to be higher than those in serum, especially in the antibiotic-refractory group.
To emphasize the differences in antibody responses to B burgdorferi and the LD-associated autoantigens in refractory and responsive arthritis, we plotted IgG1 versus IgG4 absorbance values and IgG1 versus IgG2 values in SF in the 31 patients with refractory arthritis and in the 16 patients with responsive arthritis (Figure 3) . With B burgdorferi, the amount of IgG1 antibodies was significantly greater than that of IgG4 antibodies in both the responsive and refractory groups ( Figure 3B ). In contrast, the levels of IgG4 antibodies to each of the 3 autoantigens were similar to or greater than the levels of IgG1 autoantibodies in the responsive and refractory groups, and these differences were statistically significant for MMP-10 and ECGF values. Although the mean levels of IgG1 or IgG4 autoantibodies in the patients with refractory arthritis were not significantly different from those in the patients with responsive arthritis, several patients in the refractory group had particularly high levels of IgG4 ECGF or Apo B-100 autoantibodies.
As with IgG1 and IgG4 values, the levels of IgG1 B burgdorferi antibodies were significantly greater than the levels of IgG2 antibodies to the organism in both the refractory and responsive groups ( Figure 3A) . However, for ECGF, the levels of IgG2 autoantibodies in SF were significantly greater than IgG1 levels in both the responsive and refractory groups, and for MMP-10 and Apo B-100, the levels of IgG1 and IgG2 autoantibodies in SF were similar in both the responsive and refractory groups. Thus, although the differences were greater for the IgG1 and IgG4 autoantibody comparisons, there was still reversal of the normal ratio of the IgG1 and IgG2 antibodies.
When IgG4 autoantibody values in SF were correlated with those of the other subclasses, only limited correlations were observed. For ECGF, IgG4 levels correlated with IgG1 values (r = 0.4, P = 0.01) and with IgG2 values (r = 0.7, P < 0.0001) (data not shown). However, for MMP-10 and Apo B-100, there were no correlations between IgG4 autoantibody levels and those of the other subclasses. This suggests that IgG subclass responses to specific autoantigens are variable and are not simply a reflection of total IgG autoantibody levels.
Cytokine and chemokine levels in serum and SF. Because antibody subclasses may be determined by the cytokine environment, the levels of 14 cytokines or chemokines representative of innate, Th1, Th2, and Th17 responses were measured in serum and SF from 21 patients with refractory arthritis and 9 patients with responsive arthritis for whom enough sample remained. In SF, the levels of most mediators were greater in the refractory group than in the responsive group, and these differences reached statistical significance for a number of innate, Th1, Th2, and Th17 mediators ( Figure 4A ). In contrast, the levels of most mediators in serum were much lower than in SF, and the values were similar in the responsive and refractory groups (Figure 4B) . The only exception was significantly higher serum levels of IL-4 in the refractory group. Thus, SF in patients with antibiotic-refractory arthritis was highly polarized toward Th1 and innate cytokine responses, but most of these patients also had moderate levels of Th17 mediators and low levels of Th2 cytokines, which could presumably still support the development of IgG4 antibody responses.
Correlations of SF autoantibodies with histologic findings in synovial tissue. In 13 patients with refractory Lyme arthritis in whom synovectomies were performed, synovial tissue was available for correlation of antibody levels with synovial pathology. In these patients, the surgical procedure was usually performed >1 year after oral and IV antibiotic treatment for B burgdorferi infection. Synovial tissue was not available in the responsive group because their arthritis resolves with antibiotic therapy, and therefore these patients do not undergo synovectomies.
When the levels of each of the 3 LD-specific autoantibodies in SF were correlated with the rankings for each histologic finding in synovial tissue, IgG4 antibody levels to each of the 3 autoantigens correlated directly with the magnitude of fibrosis and obliterative microvascular lesions in the tissue ( Figure 5 ). IgG4 antibody levels did not correlate with 11 other histologic findings, including lining layer thickness, global cellular infiltration, lymphoid aggregates, sublining layer vascularity, and the numbers of plasma cells, B cells, macrophages, T cells, endothelial cells, myeloid dendritic cells, or fibroblasts. Additionally, autoantibody levels of the other IgG subclasses did not correlate directly with any histologic finding. Moreover, none of the subclasses of B burgdorferi antibodies correlated with any histologic finding (data not shown). Finally, there was no correlation between serum autoantibody responses and synovial histology. Thus, the only significant correlations were between the levels of IgG4 autoantibodies to MMP-10, ECGF, and Apo B-100 in SF and the magnitude of fibrosis and obliterative microvascular lesions in synovial tissue.
Expression of mRNA for IgG subclasses and histologic analysis of IgG subclasses in synovial tissue. Expression of mRNA for IgG antibody subclasses was determined in synovial tissue from 14 patients with antibiotic-refractory Lyme arthritis and for comparison, from 5 patients each with RA or OA. Rather than responses to specific antigens, this analysis measured the total expression of all IgG heavy chains, which determines the antibody subclass. Of the 14 patients with Lyme arthritis, 10 had high expression of IgG1 heavy chains, with lower expression of IgG2 and IgG3 heavy chains ( Figure 6A ). Although expression of IgG4 heavy chains was low in most patients with Lyme arthritis, several patients had especially high IgG4 expression. Expression of mRNA for each subclass was similar in patients with Lyme arthritis and patients with RA, the prototypic form of chronic inflammatory arthritis, whereas patients with OA, a minimally inflammatory form of arthritis, had very low expression of each IgG subclass.
Synovial tissue samples from 10 patients with antibiotic-refractory Lyme arthritis were subjected to histologic staining for antibodies of each subclass. Consistent with the mRNA expression data, there was a range of plasma cell abundance, but plasma cell staining was found in the same areas as IgG subclass staining (results not shown). In Figure 6B , immunohistologic staining for all 4 IgG subclasses is shown for 2 patients, one (patient 1) with especially large numbers of IgG4-staining cells and the other (patient 2) with small numbers of IgG1-and IgG4-staining cells.
DISCUSSION
In this study, we found that the IgG antibody subclasses to B burgdorferi were distinct from those of 3 LDassociated autoantibodies. B burgdorferi antibodies were primarily of the IgG1 and IgG3 subclasses, which are antibodies important for the opsonization of pathogens (13) . In contrast, the LD autoantibodies were mainly of the IgG2 and IgG4 subclasses, and these responses were found primarily in patients with Lyme arthritis, especially in SF, implying that some of these antibodies may be produced locally in synovial tissue. In support of this idea, a subgroup of patients with refractory arthritis had marked expression of mRNA for IgG4 antibodies and large numbers of IgG4-staining plasma cells in synovial tissue. Because patients with Lyme arthritis usually had undetectable levels of IgG4 antibodies to B burgdorferi in SF, it seems likely that IgG4-staining plasma cells were producing primarily autoantibodies. It was not possible to compare these findings with those in patients with antibiotic-responsive arthritis, since they do not undergo synovectomies.
The only exception to these generalizations were the significantly higher levels of IgG3 Apo B-100 autoantibodies in the serum of patients with Lyme carditis compared with those in patients with other manifestations of LD. Several factors may play a role. First, since B burgdorferi acquires essential membrane components, such as cholesterol, from its host (22) , immune processing of the organism early in the disease may lead to crossreactive IgG3 autoantibody responses to Apo B-100. But why is this finding prominent only in patients with Lyme carditis? In murine Lyme carditis, the heart muscle has a macrophage predominance unlike that in affected joints (23) . Based on experience with atherosclerosis (24), myeloperoxidases from macrophages, and to a lesser degree from neutrophils, oxidize low-density lipoproteins (LDLs), including Apo B-100, and oxidized LDLs may contribute to Apo B-100 antigenicity.
We have previously reported total IgG antibody responses to B burgdorferi (25) and the 3 known LD autoantigens (7) (8) (9) in patients with each of the 3 stages of LD, as was done here with IgG subclasses. Both total and subclass IgG antibody responses to B burgdorferi showed gradually increasing antibody levels over the course of the disease. In addition, with both total and subclass determinations, the most prominent autoantibody responses were in SF in patients with Lyme arthritis. In previous studies, autoantibody-positive patients with erythema migrans usually had only B cell responses to a given autoantigen, without detectable T cell responses. In contrast, patients with Lyme arthritis, particularly those with refractory arthritis, often had both T and B cell responses to the antigen (7-9), which is a further indication of maturation of the autoimmune response in late disease.
In patients with antibiotic-refractory Lyme arthritis, we previously showed that total IgG autoantibodies to the 3 LD-associated autoantigens correlated with obliterative microvascular lesions, fibrosis, or fibroblast proliferation in synovial tissue (8, 9, 21) . We found here that it was specifically the IgG4 subclass of these autoantibodies that correlated directly with the magnitude of obliterative microvascular lesions and the degree of fibrosis. Autoantibodies of the other subclasses did not have this association. Obliterative vascular lesions appear to be a unique feature of the synovial tissue in Lyme arthritis and are not found in other forms of chronic inflammatory arthritis, including RA (21) .
The overall profile of IgG antibody subclass responses in antibiotic-refractory Lyme arthritis has similarities with that in RA. The finding of increased levels of IgG antibodies in some RA patients was first noted years ago (26) , but interest in the role of IgG4 autoantibodies in rheumatic diseases has increased recently (27) (28) (29) . In RA, IgG1 antibodies are most prominent, as might be expected, but IgG4 antibodies are next most prominent (27, 30) , which is surprising given that they are normally the least abundant subclass (13) . As was seen here with synovial tissue in Lyme arthritis, antibodies of each IgG subclass were found in RA synovial tissue, and in some patients, IgG4 antibodies were particularly prominent (28) . The subgroup of RA patients with elevated levels of serum IgG4 antibodies had higher disease activity, higher levels of rheumatoid factor and anti-citrullinated protein autoantibodies (ACPAs), and a poor response to diseasemodifying antirheumatic drugs (28) , suggesting that serum IgG4 antibodies define a specific clinical phenotype with more severe disease. However, the specificities of these autoantibodies are different in RA from those in Lyme arthritis. In RA, IgG4 autoantibodies to rheumatoid factor, ACPAs, or anti-carbamylated protein antibodies have been noted in almost half of patients (26, 29, 30 ). In contrast, these RA-associated autoantibodies are not features of the autoantibody response in Lyme arthritis, and autoantibodies to the 3 LD-associated autoantigens studied here are found rarely, if at all, in RA (7-9).
The recently described "IgG4-related disease" has further increased interest in the role of this IgG subclass in rheumatic diseases. The histologic hallmarks of IgG4-related disease include lymphoplasmacytic infiltrates, storioform ("woven mat") fibrosis, and predominance of IgG4-expressing plasma cells in target tissues (31) (32) (33) . This description is broadly reminiscent of findings in synovial tissue in certain patients with refractory Lyme arthritis. In IgG4-related disease, CD4+SLAMF7+ cytotoxic lymphocytes are thought to be the principal drivers of the disease (34) . In contrast, the role of IgG4 antibodies is less clear. IgG4 antibodies are poor binders to Fc receptors and complement and they are not usually able to crosslink antigen or form immune complexes due to Fab-arm exchange. Therefore, for the most part, they are thought to blunt the inflammatory response resulting from chronic antigenic exposure by competing with other IgG subclasses to bind antigen at sites of inflammation (35) .
On the other hand, in a murine model of IgG4-related disease, passive transfer of either patients' IgG4 or IgG1 antibodies to neonatal mice resulted in pancreatic and salivary gland injuries reminiscent of those in human IgG4-related disease (36) . Additionally, in pemphigus, IgG4 autoantibodies to desmoglein play a direct role in the disruption of the epithelial cell surface, leading to the blistering lesions of the disease (37) . Moreover, in lymphatic filariasis, IgG4 antibodies from asymptomatic individuals suppressed granulocytes, whereas IgG4 antibodies from symptomatic patients did not (38) . Thus, under certain circumstances, the usual antiinflammatory effects of IgG4 antibodies may be altered, resulting in loss of their usual suppressive function, or these antibodies may develop a direct pathogenic role.
In antibiotic-refractory Lyme arthritis, the marked proinflammatory cytokine milieu in joints, which is enriched for innate, Th1, Th2, and Th17 mediators, may alter the function of IgG4 autoantibodies. As shown previously and again here, the levels of proinflammatory cytokines such as IL-6, TNF, and IFNc are greater in the SF of patients with antibiotic-refractory arthritis (39, 40) , and these cytokines are present in their synovial tissue (41) . In addition, we previously found that total IgG ECGF autoantibody levels in SF correlated strongly with SF IL-17 and IL-23 values in patients with refractory arthritis, whereas in patients with responsive arthritis, ECGF antibody levels correlated with IL-10 values (42) . Similarly, in the present study, the subclasses of ECGF autoantibodies (IgG1, IgG2, and IgG4) in SF correlated strongly with Th17 cytokine mediators in the refractory group, but not in the responsive group. Moreover, the levels of several Th2 mediators, although low, may still be adequate to support IgG4 antibody production or effector functions. To gain further insights as to whether IgG4 autoantibodies may have a protective or pathologic role in refractory Lyme arthritis, it will be important to compare the affinity and function of LDassociated IgG4 autoantibodies in patients with responsive or refractory arthritis (15) .
In summary, an awareness of IgG4 autoantibodies is increasing in rheumatic diseases. In LD, the IgG subclasses of LD-associated autoantibodies were distinct from those of B burgdorferi antibodies. Moreover, LDassociated IgG4 autoantibodies in patients with refractory arthritis correlated with specific synovial pathology, suggesting that these autoantibodies may play a functional role in this postinfectious complication of LD. Increased levels of IgG4 antibodies are not found in all patients with Lyme arthritis or RA, and therefore they are not an invariant component of disease pathogenesis. However, they may have an additive role in inflammatory processes, resulting in more severe disease phenotypes. 1844 SULKA ET AL
